1. Fitzpatrick, R., Davey, C., Buxton, M. J., & Jones, D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 14, 1–74.
2. Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ, 7351, 1417–1422.
3. Hobart, J., Cano, S., Zajicek, J., & Thompson, A. (2007). Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations. Lancet Neurology, 1094–1095.
4. Hobart, J. C., & Cano, S. (2009). Improving the evaluation of therapeutic interventions in multiple sclerosis: The role of new psychometric methods. Health Technology Assessment, 12, 1–200.
5. US Department of Health & Human Services FDA. (2009). Patient reported outcome measures: Use in medical product development to support labelling claims. Retrieved August 2010 from http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation?guidance/default.htm .